Suchergebnisse - "Koopman, Jan Pieter R"

PubPharm (22)

1

Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine : safety and immunogenicity of a fractional booster dose

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2024

von Roozen, G. | Prins, M. | Prins, C. | +18

2

Boostability after single-visit pre-exposure prophylaxis with rabies vaccine : a randomised controlled non-inferiority trial

enthalten in: The Lancet. Infectious diseases | 2024

von Overduin, L. | Koopman, J. | Prins, C. | +7

3

Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination : a non-inferiority, randomized-controlled trial

enthalten in: NPJ vaccines | 2024

von Prins, M. | Roozen, G. | Pothast, C. | +21

4

Protective efficacy of short-term infection with Necator americanus hookworm larvae in healthy volunteers in the Netherlands : a single-centre, placebo-controlled, randomised, controlled, phase 1 trial

enthalten in: The Lancet. Microbe | 2023

von Hoogerwerf, M. | Janse, J. | Kuiper, V. | +14

5

Changes in pro inflammatory and regulatory immune responses during controlled human schistosome infection and the development of clinical symptoms

enthalten in: bioRxiv.org | 2023

von Houlder, E. | Stam, K. | Koopman, J. | +12

6

Safety and infectivity of female cercariae in Schistosoma-naïve, healthy participants : a controlled human Schistosoma mansoni infection study

enthalten in: EBioMedicine | 2023

von Koopman, J. | Houlder, E. | Janse, J. | +22

7

Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection : a randomised, double-blind, placebo-controlled study in the Netherlands

enthalten in: The Lancet. Infectious diseases | 2023

von van der Plas, J. | Kuiper, V. | Bagchus, W. | +22

CommentIn: Lancet Infect Dis. 2023 Oct;23(10):1102-1103. - PMID 37414067

8

Uganda Schistosomiasis Symposium 2023 : understanding morbidity drivers and developing controlled human infection models for vaccine research

enthalten in: Trends in parasitology | 2023

von Egesa, M. | Kiberu, D. | Sanya, R. | +10

9

Establishing a single-sex controlled human Schistosoma mansoni infection model for Uganda : protocol for safety and dose-finding trial

enthalten in: Immunotherapy advances | 2023

von Abaasa, A. | Egesa, M. | Driciru, E. | +20

10

Excretion patterns of Schistosoma mansoni antigens CCA and CAA by adult male and female worms, using a mouse model and ex vivo parasite cultures

enthalten in: Parasitology | 2022

von Casacuberta-Partal, M. | van Lieshout, L. | van Diepen, A. | +8